Cytochrome P450 polymorphism - Molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 3, 2008, Pages 307-318

  Tomaszewski, Piotr ^a   Kubiak Tomaszewska, Grazyna ^a   Pachecka, Jan ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CYP inducers; CYP inhibitors; CYP isoenzymes; CYP substrates; Drug biotransformation; Repressors of CYP genes

Indexed keywords

BILE ACID; CHOLESTEROL; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 ISOENZYME; DRUG METABOLITE; KETONE BODY; LEUKOTRIENE; OXYSTEROL; PROSTACYCLIN; PROSTAGLANDIN; RETINOL; STEROID HORMONE; UNINDEXED DRUG; VITAMIN D; XENOBIOTIC AGENT;

ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; DRUG METABOLISM; DRUG OXIDATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME LOCALIZATION; FATTY ACID METABOLISM; GENETIC POLYMORPHISM; HUMAN; PHARMACOGENETICS; PROSTAGLANDIN METABOLISM;

CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; ISOENZYMES; PHARMACOKINETICS; POLYMORPHISM, GENETIC; XENOBIOTICS;

EID: 45849138843     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ingelman-Sundberg M., Daly A.K., Nebert D.W. (ed.): Human CYP Allele Nomenclature Committe: Allele nomenclature for cytochrome P450 enzymes. www.cypalleles.ki.se.
2. Gonzalez F.J.: Pharmacol. Rev. 40, 243 (1988) [errata: Pharmacol. Rev. 41, 91 (1989)].
3. Source. Stanford University, Genetics Department: www.stnford.edu/cgi- bin/source/surcesearch.
4. Norlin M., Chiang J.Y.: Biochem. Biophys. Res. Commun. 316, 158 (2004).
5. Wu Z.L., Bartelson C.J., Ham A.J., Guengerich F.P.: Arch. Biochem. Biophys. 445, 138 (2006).
6. UniProt - The Universal Protein Knowledge-base: www.expasy.org/uniprot.
7. Pikuleva I.A.: Pharmacol. Ther. 112, 761 (2006).
8. Axelson M., Shoda J., Sjovall J., Toll A., Wikvall K.: J. Biol. Chem. 267, 1701 (1992).
9. Chiang J.Y.: J. Hepatol. 40, 539 (2004).
10. Russell D.W.: Annu. Rev. Biochem. 72, 137 (2003).
11. Kroetz D.L., Zeldin D.C.: Curr. Opin. Lipidol. 13, 273 (2002).
12. Kalapos M.P.: Biochim. Biophys. Acta 1621, 122 (2003).
13. Taimi, Helvig C., Wiśniewski J., Ramshaw H., White J., Amad M., Korczak B., Petkovich M.: J. Biol. Chem. 279, 77 (2004).
14. Sakaki T., Kagawa N., Yamamoto K., Inouye K.: Front. Biosci. 10, 119 (2005).
15. Coleman M.: Human Drug Metabolism: An Introduction. pp. 5-286, Wiley, Hoboken 2005.
16. Evans G. (Ed.): A Handbook of Bioanalysis and Drug Metabolism. pp. 208-376, CRC Press, Oxford 2004.
17. rd ed., Kluwer Academic/ Plenum Publishers, New York 2005.
18. Wójcikowski J., Pichard-Garcia L., Maurel P., Daniel W.A.: Brit. J. Pharmacol. 138, 1465 (2003).
19. Estabrook R.W.: Drug Metab. Dispos. 31, 1461 (2006).
20. Terry K.L., Titus-Ernstoff L., Garner E.O., Vitonis A.F., Cramer D.W.: Cancer Epidem. Biomarker Prev. 12, 187 (2003).
21. Wang X.D.: Alcohol 35, 251 (2005).
22. Mahadevan B., Marston C.P., Luch A., Dashwood W.M., Brooks E., Pereira C., Doehmer J., Baird W.M.: Int. J. Cancer 120, 1161 (2007).
23. Girennavar B., Jayaprakasha G.K., Patil B.S.: J. Food Sci. 72, C417 (2007).
24. Guo L-Q., Fuuda K., Ohita T., Yamazoe Y.: Drug Metab. Dispos. 28, 766 (2000).
25. Murray M: Clin. Exp. Pharmacol. Physiol. 24, 465 (1997).
26. Chen W., Chiang J.Y.: Gene 313, 71 (2003).
27. Eloranta J.J., Kullak-Ublick G.A.: Arch. Biochem. Biophys. 433, 397 (2005).
28. Handschin Ch., Meyer U.A.: Pharmacol. Rev. 55, 649 (2003).
29. Kliewer S.A., Goodwin B., Willson T.: Endocrine Rev. 23, 687 (2002).
30. Rusmore T.H., Kong A.N.: Curr. Drug Metab. 3, 481 (2002).
31. Vang O., Frandsen H., Hansen K., Sorensen J.N., Sorensen H. Andersen O.: Metabolism 50, 1123 (2001).
32. Hara H., Adachi T.: Mol. Pharmacol. 61, 194 (2002).
33. Hong Ch-Ch., Tang B.-K., Hammond G.L., Tritchler D., Yaffe M., Boyd N.F.: Breast Cancer Res. 6, R352 (2004) .
34. Genatlas Gene Database: www.genatlas.org.
35. Human Gene Lynx: www.genelynx.org.
36. IUBMB Enzyme Nomenclature: www.iubmb.org.
37. Entrez Protein. NCBI Sequence Viever v. 2.0. National Center for Biotechnology Information: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmddb.
38. Robertson P., DeCory H., Madan A., Parkinson A.: Drug Metab. Dispos. 28, 664 (2000).
39. de los Cobos J.P., Sinol N., Trujols J., del Rio E., Banulus E., Luguero E., Meneyo A., Queralto J.M., Bajget M., Alvarez E. and the Barcelona Group for Addiction Genetics: Drug Alcohol Depend. 89, 190 (2007).
40. Dixit V., Hariparsad N., Li F., Desai P., Thummel K.E., Unadkat J.D.: Drug Metab. Dispos. 35, 1853 (2007).
41. Lee H-K., Lewis L.D., Tsongalis G.J., McMullin M., Schur B.C., Wong S.H., Yeo KT. J.: Clin. Chim. Acta 367, 196 (2006).
42. Edwards R.J., Price R.J., Watts P.S., Renwick A.B., Tredger J.M., Boobis A.R., Lake B.G.: Drug Metab. Dispos. 31, 282 (2003).
43. DeVane C.L., Markowitz J.S., Carson S.W., Boulton D.W., Gill H.S., Nahas Z., Risch S.C.: J. Clin. Psychopharmacol. 20, 347 (2000).